Samuel Oschin Cancer Center
Los Angeles, California 90048
1 studies enrolling now · 3 studies all time
What they study most
Head and Neck Squamous Cell Carcinoma (HNSCC), Locally Advanced or Metastatic Non Small Cell Lung Cancer, Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
Studies at this site
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Recruiting now
- Phase 3 Study to Treat Patients With Soft Tissue Sarcomas — Completed
- Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients — Stopped early